Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/17/20
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 08/06/24
End: 12/31/25
Due: 12/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| VBI-S for the Treatment of Hypotension in Hypovolemic Septic Shock Patients | NCT04257136 | Vivacelle Bio | user2@example.com | None | 2020-02-17 | 2023-12-31 | 2024-12-31 | - | - | 2025-07-14 |
| A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02) | NCT06072430 | Vivacelle Bio | user2@example.com | None | 2024-08-06 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |